scispace - formally typeset
A

Anand Devaraj

Researcher at National Institutes of Health

Publications -  166
Citations -  7845

Anand Devaraj is an academic researcher from National Institutes of Health. The author has contributed to research in topics: Medicine & Lung cancer. The author has an hindex of 33, co-authored 123 publications receiving 5136 citations. Previous affiliations of Anand Devaraj include Imperial College London & National Health Service.

Papers
More filters
Journal ArticleDOI

Lung cancer screening provides an opportunity for early diagnosis and treatment of interstitial lung disease

TL;DR: The extent of abnormality on CT and severity of lung function impairment, but not symptoms were the most important factors in differentiating ILA from ILD.
Journal ArticleDOI

Immediate smoking cessation support versus usual care in smokers attending a targeted lung health check: the QuLIT trial

TL;DR: The provision of immediate smoking cessation support is associated with a substantial increase in quit rates at 3 months, and further research is needed to investigate longer-term outcomes and to refine future service delivery.
Journal ArticleDOI

A survey of UK percutaneous lung biopsy practice: current practices in the era of early detection, oncogenetic profiling, and targeted treatments

TL;DR: There are striking variations among surveyed UK radiologists performing lung biopsy in decision-making, pre-biopsy work-up, post-biops monitoring, management of pneumothorax, and discharge, which suggest a need for new updated national percutaneous lungBiopsy guidelines.
Journal ArticleDOI

Genomic–transcriptomic evolution in lung cancer and metastasis

Carlos Martínez-Ruiz, +280 more
- 12 Apr 2023 - 
TL;DR: In this paper , the authors used paired whole-exome and RNA sequencing data to investigate intratumour transcriptomic diversity in 354 non-small cell lung cancer tumours from 347 out of the first 421 patients prospectively recruited into the TRACERx study.
Journal ArticleDOI

Perinodular Vascularity Distinguishes Benign Intrapulmonary Lymph Nodes From Lung Cancer on Computed Tomography

TL;DR: A novel imaging marker that can help to differentiate between benign and malignant pulmonary nodules is described, however, attachment of a nodule to a pleural surface should not be used in isolation to distinguish IPLNs from lung malignancy.